share_log

Kala Pharmaceuticals Q3 EPS $(3.41) Misses $(2.15) Estimate

Kala Pharmaceuticals Q3 EPS $(3.41) Misses $(2.15) Estimate

卡拉制藥第三季度每股收益(3.41 美元)未達美元(2.15)預期
Benzinga ·  2023/11/13 08:11

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(3.41) per share which missed the analyst consensus estimate of $(2.15) by 58.6 percent. This is a 61.77 percent increase over losses of $(8.92) per share from the same period last year.

卡拉制藥(納斯達克股票代碼:KALA)公佈季度每股虧損3.41美元,比分析師共識估計的2.15美元(2.15美元)低58.6%。這比去年同期每股虧損8.92美元(8.92美元)增加了61.77%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論